Matthew Michelson ^UDM

Dr. Matthew Michelson serves as the CEO of Readout AI, a company at the forefront of transforming in-vivo and clinical trial data analysis. With a Ph.D. background, he brings a wealth of experience to lead the charge in reducing the time and cost associated with data interpretation. Readout AI's innovative platform empowers users to effortlessly analyze trial data, automating statistical analysis and generating clear findings presented in tables, paragraphs, and even abstract summaries. This revolutionary tool liberates scientists, providing interpretable results in seconds and revolutionizing the landscape of data-driven insights in the field.